Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis
Authors:
- 14 October 2009
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 108 (6) , 1337-1345
Abstract
The transcription factor NF‐κB is essential for osteoclastogenesis and is considered an immune‐modulator of rheumatoid arthritis and inflammatory osteolysis. Activation of NF‐κB subunits is regulated by the upstream IκB kinase (IKK) complex which contains IKKα, IKKβ, and IKKγ; the latter also known as NF‐κB essential modulator (NEMO). The role of IKKα and IKKβ in the skeletal development and inflammatory osteolysis has been described, whereas little is known regarding the role of NEMO in this setting. Typically, signals induced by RANK ligand (RANKL) or TNF prompt oligomerization of NEMO monomers through the coiled‐coil‐2 (CC2) and leucine zipper (LZ) motifs. This step facilitates binding to IKKs and further relaying signal transduction. Given the central role of NF‐κB in osteoclastogenesis, we asked whether NEMO is essential for osteoclastogenesis and whether interruption of NEMO oligomerization impedes osteoclast differentiation in vitro and in vivo. Using cell‐permeable short peptides overlapping the CC2 and LZ motifs we show that these peptides specifically bind to NEMO monomers, prevent trimer formation, and render NEMO monomers susceptible for ubiquitin‐mediated degradation. Further, CC2 and LZ peptides attenuate RANKL‐ and TNF‐induced NF‐κB signaling in bone marrow‐derived osteoclast precursors (OCPs). More importantly, these peptides potently inhibit osteoclastogenesis, in vitro, and arrest RANKL‐induced osteolysis, in mice. To further ascertain its role in osteoclastogenesis, we were able to block osteoclastogenesis using NEMO siRNA knockdown approach. Collectively, our data establish that obstruction of NEMO oligomerization destabilizes NEMO monomers, inhibits NF‐κB activation, impedes osteoclastogenesis and arrests inflammatory osteolysis. Thus, NEMO presents itself as a promising target for anti‐osteolytic intervention. J. Cell. Biochem. 108: 1337–1345, 2009.Keywords
This publication has 36 references indexed in Scilit:
- Involvement of linear polyubiquitylation of NEMO in NF-κB activationNature Cell Biology, 2009
- Cutting Edge: The IκB Kinase (IKK) Inhibitor, NEMO-Binding Domain Peptide, Blocks Inflammatory Injury in Murine ColitisThe Journal of Immunology, 2007
- Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activationNature Cell Biology, 2006
- Inhibition of inflammatory bone erosion by constitutively active STAT‐6 through blockade of JNK and NF‐κB activationArthritis & Rheumatism, 2005
- Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1)Proceedings of the National Academy of Sciences, 2005
- IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone lossJournal of Experimental Medicine, 2005
- NEMO Mutations in 2 Unrelated Boys With Severe Infections and Conical TeethPediatrics, 2005
- IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammationNature, 2005
- Inflammatory Diseases: Is Ubiquitinated NEMO at the Hub?Current Biology, 2004
- Inhibition of NF-κB Activation by Peptides Targeting NF-κB Essential Modulator (NEMO) OligomerizationJournal of Biological Chemistry, 2004